12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Company News  |  Other News

Corvas other research news

CVAS received a $599,000 Phase I SBIR grant from the National Institute of Allergy...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >